-
Anxiety, mood, depression and chronic pain
David M. Heckman PharmaceuticalWhich drug? What dose? These are the questions we focus on when we interact with a chronic pain patient. Certainly, we believe, there must be a magic pill or patch that will erase our patient's pain and (within the 15 minutes allowed by payers) send him or her out of our office eternally grateful and forever smiling.
-
Puerto Rico’s pharmaceutical industry faces post-Maria uphill battle
Michelle R. Matisons PharmaceuticalProcter & Gamble, Johnson & Johnson, Eli Lily, Pfizer, GlaxoSmithKline, Merck, Novartis. These are just a few of the 89 approved pharmaceutical companies using Puerto Rico as a manufacturing hub.
-
CVS does battle with our opioid problem
Jason Poquette PharmaceuticalThe company that banned cigarette sales from its stores in 2014 is planning to take on the opioid epidemic. Last week, CVS announced their intentions to tighten their policies and expand programs related to narcotic prescribing and dispensing.
-
Lack of support sinks Senate’s latest healthcare bill
Seth Sandronsky Healthcare AdministrationSen. Susan Collins (R-Maine) dealt a fatal blow Monday evening to the Graham-Cassidy healthcare bill to repeal the Affordable Care Act, aka Obamacare. She joined fellow Sens. John McCain (R-Ariz.) and Rand Paul (R-Ky.) in opposing the measure, leaving the Republicans' 52-48 majority over the Democrats short of the required 50 votes for passage under procedures from the fiscal year 2017 budget resolution.
-
With time running out, GOP senators revise healthcare bill
Seth Sandronsky Healthcare AdministrationIt's do or die this week for the healthcare bill from Sens. Lindsey Graham (R-S.C.) and Bill Cassidy (R-La.) to overturn the 2010 Affordable Care Act, aka Obamacare. A summary of the revised Graham-Cassidy bill reveals increased funding of block grants to some states to attract support from Sens. Lisa Murkowski (R-Alaska) and Susan Collins (R-Maine), according to The Washington Post. State block grants would replace federal funding under the GOP's latest bid to repeal the ACA.
-
Healthcare industry continues to shine in job creation
Scott E. Rupp Healthcare AdministrationWith all the drama surrounding the politics of repealing the Affordable Care Act, the good news for the healthcare economy is that it continues to add jobs. The sector creating another 20,000 in August on top of the 39,000 or so in July.
-
Study: White children more likely to receive unnecessary antibiotics from…
Lynn Hetzler Medical & Allied HealthcareWhite children were nearly twice as likely to receive antibiotics for viral illnesses from emergency departments as compared with minority children, according to a new study. Viral respiratory tract infections are a leading cause of pediatric visits to emergency departments.
-
We are failing the opioid crisis
David M. Heckman PharmaceuticalOur politicians are in the process of wasting tax dollars on ineffective and misguided efforts to resolve the opioid crisis. These funds will likely be spent by many of the people responsible for the crisis.
-
Senate GOP’s last-gasp bill to undo Obamacare faces strong opposition
Seth Sandronsky Healthcare AdministrationTime is running out in the Republican Party's quest to undo the Affordable Care Act, aka "Obamacare." A bill from Sens. Lindsey Graham (R-S.C.) and Bill Cassidy (R-La.) that needs 50 votes by Sept. 30 (end of the budget reconciliation process) is facing dissent across the U.S.
-
5 tips for getting the most from your pharmacy CE conferences
Jason Poquette PharmaceuticalHow valuable have the last few pharmacy continuing education conferences been to your practice? Those of us who have been attending such conferences for decades understand that some are interesting. Others are not. A cramped room and uninspiring speaker can make you feel like you wasted your money, not to mention your time.
All Pharmaceutical Articles